| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.
|
Arch Gen Psychiatry
|
2004
|
3.64
|
|
2
|
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.
|
Neuropsychopharmacology
|
2004
|
2.87
|
|
3
|
Rates of violence in patients classified as high risk by structured risk assessment instruments.
|
Br J Psychiatry
|
2014
|
2.22
|
|
4
|
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
|
Biol Psychiatry
|
2005
|
2.14
|
|
5
|
Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
|
Arch Gen Psychiatry
|
2002
|
2.01
|
|
6
|
Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.
|
Am J Psychiatry
|
2004
|
1.96
|
|
7
|
Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis.
|
Behav Pharmacol
|
2009
|
1.90
|
|
8
|
Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.
|
Alcohol Clin Exp Res
|
2007
|
1.86
|
|
9
|
Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations.
|
Arch Gen Psychiatry
|
2003
|
1.81
|
|
10
|
Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence.
|
Biol Psychiatry
|
2008
|
1.76
|
|
11
|
Preliminary evidence for medication effects on functional abnormalities in the amygdala and anterior cingulate in bipolar disorder.
|
Psychopharmacology (Berl)
|
2005
|
1.67
|
|
12
|
Impaired visual cortical plasticity in schizophrenia.
|
Biol Psychiatry
|
2012
|
1.67
|
|
13
|
Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
|
J Clin Psychiatry
|
2015
|
1.62
|
|
14
|
DNMT3A mutation is a poor prognosis biomarker in AML: results of a meta-analysis of 4500 AML patients.
|
Leuk Res
|
2013
|
1.60
|
|
15
|
Extracellular metabolites in the cortex and hippocampus of epileptic patients.
|
Ann Neurol
|
2005
|
1.55
|
|
16
|
Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample.
|
Biol Psychiatry
|
2005
|
1.55
|
|
17
|
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.
|
Biol Psychiatry
|
2005
|
1.52
|
|
18
|
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.
|
Arch Gen Psychiatry
|
2005
|
1.52
|
|
19
|
Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
|
Neuropsychopharmacology
|
2008
|
1.49
|
|
20
|
Cognitive-behavioral therapy, behavioral weight loss, and sequential treatment for obese patients with binge-eating disorder: a randomized controlled trial.
|
J Consult Clin Psychol
|
2011
|
1.43
|
|
21
|
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
|
Psychopharmacology (Berl)
|
2004
|
1.38
|
|
22
|
Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy.
|
Biol Psychiatry
|
2005
|
1.33
|
|
23
|
Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder.
|
Am J Psychiatry
|
2004
|
1.20
|
|
24
|
Glutamatergic modulation of auditory information processing in the human brain.
|
Biol Psychiatry
|
2011
|
1.20
|
|
25
|
Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients.
|
Am J Psychiatry
|
2007
|
1.17
|
|
26
|
Dopamine beta-hydroxylase gene (DbetaH) -1021C-->T influences self-reported paranoia during cocaine self-administration.
|
Biol Psychiatry
|
2006
|
1.13
|
|
27
|
Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking.
|
Biol Psychiatry
|
2005
|
1.10
|
|
28
|
Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study.
|
Psychopharmacology (Berl)
|
2006
|
1.06
|
|
29
|
Multidimensionality of the Alcohol Withdrawal Symptom Checklist: a factor analysis of the Alcohol Withdrawal Symptom Checklist and CIWA-Ar.
|
Alcohol Clin Exp Res
|
2007
|
1.05
|
|
30
|
Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam.
|
Alcohol Clin Exp Res
|
2007
|
1.03
|
|
31
|
The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity.
|
Neuropsychopharmacology
|
2013
|
1.02
|
|
32
|
Gelatin "shots" as a new method for alcohol administration in a laboratory setting.
|
Alcohol Clin Exp Res
|
2006
|
1.02
|
|
33
|
Posttraumatic stress disorder and substance use in inner-city adolescent girls.
|
J Nerv Ment Dis
|
2003
|
1.01
|
|
34
|
Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence.
|
Neuropsychopharmacology
|
2011
|
1.00
|
|
35
|
A paradigm to investigate the self-regulation of cocaine administration in humans.
|
Psychopharmacology (Berl)
|
2005
|
0.99
|
|
36
|
Imaging mass spectrometry--a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas.
|
Am J Dermatopathol
|
2012
|
0.97
|
|
37
|
Risk factors for cocaine-induced paranoia in cocaine-dependent sibling pairs.
|
Drug Alcohol Depend
|
2006
|
0.96
|
|
38
|
Using computational patients to evaluate illness mechanisms in schizophrenia.
|
Biol Psychiatry
|
2011
|
0.95
|
|
39
|
The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding.
|
Arch Gen Psychiatry
|
2011
|
0.95
|
|
40
|
Cortical gamma-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence: relationship to features of alcohol dependence and cigarette smoking.
|
Arch Gen Psychiatry
|
2005
|
0.94
|
|
41
|
Self-reported paranoia during laboratory "binge" cocaine self-administration in humans.
|
Pharmacol Biochem Behav
|
2006
|
0.94
|
|
42
|
Inter-rater reliability and concurrent validity of DSM-IV opioid dependence in a Hmong isolate using the Thai version of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA).
|
Addict Behav
|
2010
|
0.93
|
|
43
|
Cortisol levels in relation to hippocampal sub-regions in subjects with first episode schizophrenia.
|
Schizophr Res
|
2007
|
0.91
|
|
44
|
Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia.
|
Neuropsychopharmacology
|
2006
|
0.90
|
|
45
|
Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response.
|
Neuropsychopharmacology
|
2004
|
0.88
|
|
46
|
Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism.
|
Neuropsychopharmacology
|
2006
|
0.86
|
|
47
|
Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression.
|
Psychiatry Res
|
2002
|
0.86
|
|
48
|
Estradiol and tryptophan depletion interact to modulate cognition in menopausal women.
|
Neuropsychopharmacology
|
2006
|
0.86
|
|
49
|
Baseline and modulated acoustic startle responses in adolescent girls with posttraumatic stress disorder.
|
J Am Acad Child Adolesc Psychiatry
|
2005
|
0.86
|
|
50
|
Lateral ventricle volume and psychotic features in adolescents and adults with bipolar disorder.
|
Psychiatry Res
|
2011
|
0.83
|
|
51
|
Efficacy of pimozide augmentation for clozapine partial responders with schizophrenia.
|
Schizophr Res
|
2012
|
0.83
|
|
52
|
Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine.
|
Psychopharmacology (Berl)
|
2005
|
0.82
|
|
53
|
Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
|
Alcohol Clin Exp Res
|
2007
|
0.82
|
|
54
|
Self-help for binge eating disorder in primary care: a randomized controlled trial with ethnically and racially diverse obese patients.
|
Behav Res Ther
|
2013
|
0.81
|
|
55
|
Adolescent cannabis use increases risk for cocaine-induced paranoia.
|
Drug Alcohol Depend
|
2009
|
0.79
|
|
56
|
Regulation of cocaine self-administration in humans: lack of evidence for loading and maintenance phases.
|
Pharmacol Biochem Behav
|
2009
|
0.79
|
|
57
|
Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
|
Alcohol Clin Exp Res
|
2007
|
0.78
|
|
58
|
CSF sub-compartments in relation to plasma osmolality in healthy controls and in patients with first episode schizophrenia.
|
Psychiatry Res
|
2007
|
0.78
|
|
59
|
A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression.
|
Psychopharmacology (Berl)
|
2013
|
0.77
|
|
60
|
Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans.
|
Am J Addict
|
2014
|
0.77
|
|
61
|
ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia.
|
Leuk Lymphoma
|
2015
|
0.76
|
|
62
|
It is time to take a stand for medical research and against terrorism targeting medical scientists.
|
Biol Psychiatry
|
2008
|
0.75
|
|
63
|
Multidisciplinary Proactive Psychiatric Consultation Service: Impact on Length of Stay for Medical Inpatients.
|
Psychother Psychosom
|
2015
|
0.75
|